Fluorouracil Accord 50 mg/ml injeksjons-/infusjonsvæske
Sponsors
Akershus University Hospital, Helse Bergen HF
Conditions
Colorectal cancerPancreatic cancer
Phase 2
METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer – Shaping Anti-Tumor Immunity by Oxaliplatin
Active, not recruitingCTIS2022-500027-76-00
Start: 2022-10-05Target: 40Updated: 2025-05-28
The role of sonoporation-enhanced treatment with Gemcitabine, Nab-Paclitaxel and FOLFIRINOX in patients with inoperable pancreatic cancer
Active, not recruitingCTIS2024-512176-35-00
Start: 2024-09-27Target: 60Updated: 2024-09-26